On the face of it, selling to the NHS is the same regardless of what your product is, whether that be within devices or pharmaceuticals. However, on closer inspection there are major differences between selling a drug to selling a device.
In the news this week: the CQC publishes its 2019 ‘State of Care’ report, the government proposes a new patient safety regulator, an inexpensive drug could ‘save thousands of lives a year’ from head injuries, and could British HIV-positive patients living in Spain lose their healthcare post-Brexit?
‘Smart’ hearing aids can now stream music and monitor wearers’ health, massive growth is expected in the medical devices outsourcing market, an app helps detect acute kidney injury, and a report looks at how post-Brexit regulation could affect healthcare.
A Convergence Science Centre is launched to accelerate cancer treatments, Switzerland and Lichtenstein’s Director for International Trade says the UK offers unique opportunities for export and investment, and Pfizer confirms its generics merger with Mylan.
NICE is set to review how it develops guidance on drugs, apps are a crucial step on the road to greater efficiency in care, the UK government looks to boost AI in preventative healthcare, and an ‘essential’ nursing review is scrapped.
Clinicians are stretched with both time and budgets, so it’s more important than ever to maximise time with them day-to-day. Here’s a simple guide from some of our candidates to getting the most from visits to customers.
Top roles from Star this month include Senior Product Manager, Anaemia Business Manager, Compliance Manager, Medical Manager, Medical Projects and NHS Collaboration Partner, and Social Media Director positions covering a range of territories. Read more -
The MHRA consults on how best to engage with patients and the public, the world’s first full colour 3D printing technology is used in kidney cancer surgery, and the MD of Roche Diabetes Care says it’s time for the industry to work with health systems to speed up innovation access.
Ask anyone at any level of any company and odds are they've second-guessed themselves about a decision. Occasionally these nagging feelings can topple into self-doubt and questioning your ability in your role.
A subscription-style payment model is launched to incentivise R&D in pharma and biotech, the NHS offers £750k for a company to help combat alleged pharmacy fraud, and the government sets aside £3 million to transport short-life medicines and devices in a no-deal Brexit.